logo
The current testing system for prostate cancer is failing too many men

The current testing system for prostate cancer is failing too many men

Telegraph19 hours ago
SIR – Congratulations on your campaign (Leading Article, July 26) for a targeted screening programme for prostate cancer. My own diagnosis earlier this year made me realise that a national screening test is urgently needed.
I was (and still am) asymptomatic, and have no known family history. I requested a PSA test from my GP following a chance meeting with an acquaintance who had recently been diagnosed with localised advanced prostate cancer – he had originally decided against a test, but was persuaded after learning of Sir Chris Hoy's experience. I am now being treated for localised advanced (high risk) prostate cancer.
Your reports of men having to request a PSA test from their GP several times, even with symptoms, are appalling. A friend of a family member had a similar experience. He had experienced typical symptoms and went to see his GP, who gave him various blood and other tests, but notably not a PSA test. Having sought a second opinion privately, he was then diagnosed with prostate cancer, which has spread throughout his body. I know men who have received an unenthusiastic response from their GP; other men are completely ignorant of the cancer and its symptoms.
The status quo is a disaster for men. I fully support your campaign and your call for better training and awareness for GPs.
Geoff Stevens
Harrogate, North Yorkshire
SIR – I was repeatedly refused the PSA test by GPs on the grounds that the test was too sensitive and unreliable. I eventually managed to persuade a GP to comply, but only because I refused to be placed on statins, which were to be prescribed for no other reason than my age. The results of the test were elevated but, after treatment, at least I am now one of those who will die with, hopefully not of, prostate cancer.
The worst irony of my experience was the revelation, from the nurse specialist who took my family history, that because my mother and maternal grandmother had both died of breast cancer, I was in a higher risk category. Had I known this, I might have convinced previous GPs to test my PSA earlier and maybe even qualified for prostatectomy, like younger friends and relatives with whom I have compared notes, thereby avoiding the unpleasant side effects of radiotherapy.
Dermod Malley
Halstead, Essex
SIR – All men need to be tested for prostate cancer. My husband had no signs or symptoms, but we had lost a friend to the disease, so our enlightened GP ordered a PSA test which indicated that my husband, then 55, had a problem. Our son has been tested since he was 45 years old.
My husband and his specialist fought it for 22 years but sadly he lost his battle in 2019.
Marilla Blenkin
Ashford, Kent
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bedfordshire woman with ME criticises health plan for condition
Bedfordshire woman with ME criticises health plan for condition

BBC News

time12 minutes ago

  • BBC News

Bedfordshire woman with ME criticises health plan for condition

A woman living with myalgic encephalomyelitis (ME) said she has "lost faith" in receiving "meaningful support" after the government released a new support plan for the also known as chronic fatigue syndrome (CFS), is a neurological disease which affects about 390,000 people in the UK. On 22 July the government launched a new delivery plan to improve education around the illness, as well as increase funding, research and medical training for health practitioners. Maddie Walker, 51, from Bedfordshire, said she was "disappointed" in how the plan lacked any "real change to improve the quality of life for sufferers". Ms Walker said she was healthy and active before she developed severe ME and was now unable to leave the house without a wheelchair and has carers visit her multiple times a described living with the condition as "mind-numbing" and that she felt "despondent". The condition's symptoms include fatigue, muscle and joint weakness, cognitive dysfunction and post-exertional malaise. Misdiagnosis Ms Walker was initially diagnosed with fibromyalgia with fatigue, a condition causing muscular pain all over the body. As a result of the crossover in symptoms, Ms Walker's ME was not recognised initially, leading her to be recommended treatment that was not tailored to both conditions."Something I feel really strongly about is people being given the right information at the point of diagnosis because if I had known what I was doing was harmful, I might not be in this situation."Ms Walker said she has a "terrible, really poor quality of life" and that "hundreds of thousands of people have once again been let down" by the new delivery plan. "We just aren't important enough," she said. The ME Association (MEA) said the government must go "much further" to improve medical care and funding for "much needed" biomedical research. It added that currently most research studies for ME/CFS are funded by the charity added there were numerous strengths to the plan, including the approach to broaden education about the illness in the NHS and in schools. Dr Charles Shepherd, a medical adviser with the MEA, said the plan does not align with the 2021 National Institute for Health and Care Excellence guidelines, which suggested making referral services more accessible in hospitals. Ashley Dalton, the MP for West Lancashire and minister for public health and prevention, said: "[The] plan will help tackle the stigma and lack of awareness of this condition through improved training for NHS staff." A spokesperson of Department for Health and Social Care (DHSC) said: "We acknowledge there is more to be done and will continue to build on the foundations of these actions well beyond the publication of this plan."There was a "clear commitment" to achieving "meaningful change" for the ME/CFS community, it using neighbourhood health services, the DHSC said it will ensure patients can access quality care closer to home. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.

Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency
Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency

The Independent

timean hour ago

  • The Independent

Trump's hand makeup is back during Scotland trip as he deals with chronic venous insufficiency

President Donald Trump 's hand makeup is back as he meets with world leaders between games of golf on his trip to Scotland. Photographs of the president's meeting with European Commission President Ursula von der Leyen on Sunday showed the back of his right hand apparently caked in concealer. It was also evident on Monday, ahead of his meeting with U.K. Prime Minister Sir Keir Starmer, and on Friday as he departed the White House on Marine One. Trump, 79, has persistent bruising on his hand that has previously been attributed to the large number of handshakes he gives and receives in his role as president and an aspirin regimen, though that has done little to quell speculation on social media. The bruising was acknowledged in a July 17 medical report that also diagnosed Trump with chronic venous insufficiency (CVI), a benign and common condition, prevalent in people over the age of 70. The apparent need to cover the bruising with makeup has not been explained. As the oldest president ever to be elected and take office, Trump's health and mental acuity have been a concern since his inauguration in January, though the White House is adamant he 'remains in excellent health.' In February, during a visit to the White House by President Emmanuel Macron of France, a large bruise was noticed on the back of Trump's right hand, sparking speculation about its cause. More recently, the use of makeup was noticed in photos, and questions were also raised about what appeared to be swelling around his ankles during his attendance at the FIFA Club World Cup Final. Shortly after, Press Secretary Karoline Leavitt released a letter from the White House physician confirming that a doctor had seen the president for a 'comprehensive examination,' the conclusion of which was the diagnosis of CVI — a condition in which veins struggle to manage blood flow, making it hard for blood to return to the heart. The report by Sean Barbabella, the president's physician, also noted: 'Recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen.'

Men need to discuss penile cancer — a bigger killer than testicular
Men need to discuss penile cancer — a bigger killer than testicular

Times

timean hour ago

  • Times

Men need to discuss penile cancer — a bigger killer than testicular

If you asked 100 people to name a cancer, most would probably come up with one of the more common, high-profile types such as breast, bowel, lung, prostate. Indeed, I would wager that cancer of the penis wouldn't even feature — yet it's on my mind this week following indications from a UK trial that immunotherapy can improve survival rates. The six-year EPIC study, led by the urologist Professor Amit Bahl at University Hospitals Bristol, is ongoing. However, if these initial findings are confirmed, it could offer help to prolong the lives of a significant minority of men with advanced disease, many of whom have left it too late to benefit fully from other treatments. Late presentation is all too common in penile cancer, because men are either unaware of the threat posed by early symptoms or too embarrassed to seek help. Here's what every man should know. Penile cancer is a rare condition typically not seen until middle age or beyond, but it can develop much sooner. And while it is uncommon compared with other cancers, 1 in 400 men in the UK will develop it at some point in their lives, and it kills more than twice as many people as testicular cancer. Early diagnosis not only improves the chances of a cure, it means treatment can be less invasive and less disfiguring. Or, to put it another way, early presentation may not only save your life, but your penis too. So what signs should you be looking out for? • Why is the cancer rate surging among the under-50s? Cancer can develop anywhere on the penis but typically it starts under the foreskin or on the head (glans). Early signs include areas of discolouration — often red or bluish-brown — and a persistent rash or sore that lasts longer than a month. It can also cause bleeding, an abnormal discharge, and an obvious lump, either on the penis itself or, in more advanced cases, in a lymph node in the groin. In some cases it can also tether the foreskin, making it hard to retract. Fortunately, there are many other possible causes for these symptoms. Colour changes and rashes can develop as a result of infections such as thrush (candida) or inflammatory conditions including lichen sclerosus, balanitis and psoriasis. Bleeding can be a result of trauma, including a torn frenulum (the bit underneath that connects part of the foreskin to the glans) after intercourse. Difficulty retracting the foreskin is often caused by more innocent tightening (phimosis), and lumps in the shaft can sometimes form from scarring caused by Peyronie's disease, a relatively common condition that can lead to bends in the penis when it is erect. So when you see your GP or specialist, there is a good chance the result won't be as bad as you feared — but that doesn't mean it's OK to put off that appointment. Caught early, penile cancer is relatively easy to treat, with more than 90 per cent of men still alive five years after diagnosis. However, the outlook for men with the most advanced cancer, where it has spread to other parts of the body, is bleak: no men in this group are expected to survive for five years. • Read more from Dr Mark Porter The other major advantage of early diagnosis is that often it means treatment is less invasive: the earliest suspicious lesions can be 'burnt' off using lasers or chemotherapy and immunotherapy creams. However the more established and advanced the tumour, the more aggressive the treatment required — ranging from circumcision of the foreskin and/or local excision with skin grafting to amputating the head of the penis (glansectomy), or even total removal (penectomy). If the penis has to be removed — and this includes the 'root' inside a man — then a new outlet for the bladder is fashioned between the anus and scrotum, which means he will have to sit down to pee. Luckily this should preserve continence because the sphincter and muscles that control urine flow remain intact. Chemotherapy, radiotherapy and immunotherapy are all treatment options, sometimes given before surgery to shrink tumours and afterwards to reduce the risk of spread or to control cancers that already have spread. Any man can be affected but some are more at risk than others, including smokers, those infected with the human papillomavirus (HPV, see below), men with a weakened immune system because of an underlying disease such as HIV, and those who have not been circumcised. Circumcision as a child or teenager offers protection against the disease as it reduces exposure to secretions (smegma) produced by the foreskin. • Read more expert advice on healthy living, fitness and wellbeing Conversely, an inability to retract the foreskin (phimosis) increases the risk. While often normal in young children (those under three), it affects as many as 1 in 30 men at some point — because it either persists from childhood or develops later in life owing to scarring following infection or trauma. Treatment often involves circumcision. For more information about penile cancer visit • There are more than 150 strains of the human papillomavirus (HPV) and nearly all of us will be exposed to at least one type at some stage, often through sexual contact. • Most infections don't cause significant issues and are cleared by the body, but some can cause problems ranging from tissue overgrowth, as seen in warts and verrucas, to changes that can start the cell on a pathway to cancer.• Strains 16 and 18 are responsible for the majority of penile and cervical cancer cases.• The cervical cancer vaccine, which protects against types 16 and 18, should also reduce the risk of penile cancer because it is now administered to boys and some men. However, more research is needed to determine exactly how much protection it provides.• For more information on the vaccine visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store